Watch SRPT. Know when insiders buy.
One email the day a filing lands. Free.
SRPT
Sarepta Therapeutics, Inc.
16.07
+0.06 +0.37%
USD · close Nov 13
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
75
PASS · shorts 75
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.7BP/E —DIV YIELD —FCF YIELD 4.82%REV TTM $2B −20.4%NET INCOME −$136.7MNET DEBT $276.5M52W 14.86 – 23.83SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose SRPT in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
AQR Capital Management, LLC and 1 related1.3%
STATE STREET CORPORATION7.0%
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.